Skip to content
  • About
  • Board
  • News
  • Sign Up
  • Contact

Visit

vjhemonc logo
VJOncology
Logo
  • Home (current)
  • Diseases
    Genitourinary
    Lung
    Head and Neck
    Breast
    Gynecological
    Skin
    View all Diseases
    • Topics
      Treatment
      Early Diagnosis
      Nursing
      Pharmacy
      Supportive Care
      Policy
      View all Topics
      • Conferences
        NCRI
        2019
        ISOPP
        2019
        ESMO
        2019
        EONS
        2019
        ASCO
        2019
        ELCC
        2019
        View all Conferences
        • Features
        • Podcasts
          • About
          • Board
          • News
          • Sign Up
          • Contact

        Cisplatin

        1:01
        CRT and Debio1143 for treatment of LA SCCHN
        Jean Bourhis
        3:32
        DNA damage repair mutations and poor chemotherapy response in bladder cancer
        Yair Lotan
        2:28
        Defining platinum ineligibility in mUC
        Shilpa Gupta
        1:46
        New promise in treating mBC: combining anti-AR therapy with chemotherapy
        Shilpa Gupta
        1:23
        Nrf2 inhibitors to overcome chemoresistance
        Simon Crabb
        1:37
        Radiosensitizers to increase radiotherapy efficacy
        Ananya Choudhury
        2:30
        Bladder cancer: unmet need for novel therapies
        Petros Grivas
        2:25
        The continuing role of chemotherapy for bladder cancer
        Ignacio Duran
        3:23
        Improving the current chemotherapy standard: a role for DNA methyltransferase inhibitors
        Simon Crabb
        2:47
        Current treatment landscape of triple negative breast cancer
        Adrian Harris
        3:08
        KEYNOTE-048: pembrolizumab monotherapy for frontline R/M HNSCC
        Barbara Burtness
        3:28
        Head and neck cancer challenges & cetuximab trial updates
        Quynh-Thu Le
        4:57
        Cetuximab for oropharyngeal cancer: latest data from De-ESCALaTE
        Hisham Mehanna
        2:02
        KEYNOTE-189: chemo plus pembrolizumab for NSCLC
        Marina Garassino
        2:38
        The current treatment landscape for penile cancer
        Lisa Pickering
        2:34
        Key trials that will affect the therapy landscape for NSCLC
        Benjamin Besse
        • 1
        • 2
        • Next
        vjoncology logo VJOncology is intended for Healthcare Professionals only

        By choosing to continue, you are confirming that you are a healthcare professional

        VJO needs the contact information you provide to inform you about our latest oncology news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

        Please enter your details if you would like to receive the latest oncology news and updates

        Continue
        Disease channels
        • Genitourinary
        • Lung
        • Head and Neck
        • Breast
        • Gynecological
        • Skin
        • View all
        Join our community

        Keep up-to-date via social media

        Sign up for email updates

        Get great new content delivered to your inbox

        Sign up
        mmp logo

        Magdalen Centre
        The Oxford Science Park
        Oxford OX4 4GA, United Kingdom

        VJOncology logo
        The content of VJOncology is intended for healthcare professionals
        • Cookie Policy
        • Privacy Policy
        • Terms of Use
        • Editorial Policy